Arcadia Biosciences, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Arcadia Biosciences, Inc. (RKDA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $16.35 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-13
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $98.37, a 38.57% increase year-over-year.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $70.99.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2022-03-31 was $15.07, a 93.34% decline year-over-year.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $90.98, a 29.47% decline from fiscal 2024.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $129.00, a 6.61% increase from fiscal 2023.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $121.00, a 81.23% decline from fiscal 2022.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $644.80, a 44.45% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $16.35 10-Q · filed 2026-08-13 | ||||
| 2025-12-31 | $90.98 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $92.85 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | $92.85 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | $98.37 10-Q · filed 2025-05-08 | ||||
| 2024-12-31 | $129.00 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $170.08 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | $164.76 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | $70.99 10-Q · filed 2024-05-13 | ||||
| 2023-12-31 | $121.00 10-K · filed 2025-03-25 | $121.05 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $118.35 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $118.35 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $644.80 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $6.04 10-Q · filed 2022-11-10 | ||||
| 2022-06-30 | $6.21 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | $15.07 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | $1160.80 10-K · filed 2023-03-30 | $29.02 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $33.38 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $128.45 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | $226.32 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $25.56 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $48.57 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | $52.51 10-Q · filed 2020-08-13 | ||||
| 2020-03-31 | $45.62 10-Q · filed 2020-05-13 | ||||
| 2019-12-31 | $98.69 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $7.07 10-Q · filed 2019-11-06 | ||||
| 2019-06-30 | $58.41 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $24.78 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | $43.73 10-K · filed 2020-03-25 | ||||
| 2017-12-31 | $98.95 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| New Concept Energy, Inc. (GBR) | United States | $0.004B | |
| Trio Petroleum Corp (TPET) | United States | $0.009B | |
| AleAnna, Inc. (ANNA) | United States | $0.013B | |
| BARNWELL INDUSTRIES INC (BRN) | United States | $0.014B | -2.71 |
| CKX LANDS, INC. (CKX) | United States | $0.022B | 7.62 |
| MEXCO ENERGY CORP (MXC) | United States | $0.022B | 10.07 |
| EON Resources Inc. (EONR) | United States | $0.026B | |
| Prairie Operating Co. (PROP) | United States | $0.047B | -1.72 |
| ABUNDIA GLOBAL IMPACT GROUP, INC. (AGIG) | United States | $0.057B | -1.20 |
| BATTALION OIL CORP (BATL) | United States | $0.064B |